Valuation: Navamedic ASA

Market Cap 385M 39.89M 34.9M 32.2M 29.67M 55.5M 3.84B 57.17M 385M 151M 1.88B 150M 146M 6.47B P/E 2026 *
-292x
P/E 2027 * 36.1x
Enterprise Value 505M 52.33M 45.78M 42.25M 38.92M 72.81M 5.04B 75M 505M 199M 2.47B 197M 192M 8.49B EV / Sales 2026 *
0.86x
EV / Sales 2027 * 0.73x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 week-2.13%
Current month-1.83%
1 month-3.89%
3 months-25.00%
6 months-26.04%
Current year-32.56%
1 week 16.05
Extreme 16.05
16.65
1 month 15.7
Extreme 15.7
17.45
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2019
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Chairman 66 -
Director/Board Member 60 01/06/2024
Director/Board Member - 01/06/2023
Date Insider Type Main position Quantity % Market Cap.
12/19/24 A Buy

Chief Operating Officer

10,267 0.0581%
9/9/24 A Fiscal year

Executive/Senior Manager

75,000 0.4302%
9/9/24 A Fiscal year

Chief Executive Officer

80,000 0.4589%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.13%-35.02%-57.98% 39.94M
+0.85%-0.80%+52.79%+159.97% 1,051B
+1.23%-1.53%+54.58%+59.41% 609B
+0.04%+2.58%+34.47%+84.84% 450B
+0.78%-0.71%+29.28%+23.25% 330B
+1.41%+0.58%+35.44%+40.53% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.01% 223B
-1.42%+0.80%+24.27%+57.85% 198B
-1.48%+3.43%+24.08%+70.06% 167B
Average -0.06%+0.27%+22.18%+42.24% 357.51B
Weighted average by Cap. +0.37%+0.02%+37.51%+78.95%

Financials

2026 *2027 *
Net sales 588M 60.93M 53.3M 49.19M 45.31M 84.77M 5.87B 87.32M 588M 231M 2.87B 229M 224M 9.88B 643M 66.69M 58.34M 53.84M 49.6M 92.79M 6.43B 95.58M 644M 253M 3.14B 251M 245M 10.82B
Net income -1.5M -155K -136K -125K -115K -216K -14.93M -222K -1.5M -588K -7.3M -582K -569K -25.14M 10.7M 1.11M 970K 895K 825K 1.54M 107M 1.59M 10.71M 4.21M 52.26M 4.17M 4.07M 180M
Net Debt 120M 12.44M 10.88M 10.04M 9.25M 17.3M 1.2B 17.82M 120M 47.22M 586M 46.74M 45.67M 2.02B 87.4M 9.06M 7.92M 7.31M 6.74M 12.6M 873M 12.98M 87.45M 34.39M 427M 34.04M 33.26M 1.47B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
17/07/26 NOK 16.05 0.00% 942
16/07/26 NOK 16.05 0.00% 10
15/07/26 NOK 16.05 -0.93% 2,151
14/07/26 NOK 16.20 -1.52% 5,258
13/07/26 NOK 16.45 +0.30% 1,157
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.05NOK
Average target price
23.50NOK
Spread / Average Target
+46.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock